TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Pharmarelations AB
Closing information (x1000 EUR)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover |
29,805
|
26,953
|
20,206 |
Financial expenses |
39
|
31
|
12 |
Earnings before taxes |
1,957
|
2,079
|
1,951 |
EBITDA |
1,918
|
2,098
|
1,966 |
Total assets |
10,851
|
8,825
|
7,313 |
Current assets |
10,799
|
8,766
|
7,259 |
Current liabilities |
4,184
|
3,309
|
3,113 |
Equity capital |
6,231
|
4,724
|
3,277 |
- share capital |
10
|
9
|
10 |
Employees (average) |
227
|
197
|
146 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency |
57.4%
|
53.5%
|
44.8% |
Turnover per employee |
131
|
137
|
138 |
Profit as a percentage of turnover |
6.6%
|
7.7%
|
9.7% |
Return on assets (ROA) |
18.4%
|
23.9%
|
26.8% |
Current ratio |
258.1%
|
264.9%
|
233.2% |
Return on equity (ROE) |
31.4%
|
44.0%
|
59.5% |
Change turnover |
2,773
|
8,383
|
4,705 |
Change turnover % |
10%
|
45%
|
30% |
Chg. No. of employees |
30
|
51
|
34 |
Chg. No. of employees % |
15%
|
35%
|
30% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.